![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics Reports First Quarter 2015 Financial Results
11 mai 2015 16h05 HE
|
Juno Therapeutics
Conference call to be held on Monday, May 11, 2015 at 5:00 p.m. Eastern Time
- Positive momentum on clinical trials and research continues
- Multiple strategic transactions...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics Strengthens Multiple Capabilities Through Acquisition of Stage Cell Therapeutics
11 mai 2015 16h02 HE
|
Juno Therapeutics
Transaction Provides Transformative Cell Selection and Activation Capabilities, Advanced Manufacturing Automation, Improved Supply Chain, and Lower Expected Cost of Goods
Initial Payment of...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
06 mai 2015 07h30 HE
|
Juno Therapeutics
SEATTLE, May 6, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) today announced that it will webcast its presentation at the Bank of America Merrill Lynch 2015 Health Care Conference at...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics to Report First Quarter 2015 Financial Results on Monday, May 11
05 mai 2015 08h00 HE
|
Juno Therapeutics
SEATTLE, May 5, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) will announce financial results for the first quarter of 2015 on Monday, May 11, 2015 after the close of U.S.-based...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
MedImmune and Juno Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
GAITHERSBURG, Md. and SEATTLE, April 23, 2015 (GLOBE NEWSWIRE) -- MedImmune, the global biologics research and development arm of AstraZeneca, and Juno Therapeutics, Inc., a biopharmaceutical company...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics' CAR T Cell Product Candidate JCAR017 Continues to Demonstrate Encouraging Outcomes in Pediatric Patients With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
21 avr. 2015 10h30 HE
|
Juno Therapeutics
SEATTLE, April 21, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO), a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer,...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics Announces Patent Litigation Settlement
06 avr. 2015 08h00 HE
|
Juno Therapeutics
SEATTLE, April 6, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) today announced that it entered into a settlement agreement to resolve litigation with the Trustees of the University...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics Reports Fourth Quarter and 2014 Financial Results
18 mars 2015 16h02 HE
|
Juno Therapeutics
Conference call to be held on Wednesday, March 18, 2015 at 5:00 p.m. Eastern Time
Positive momentum and progress on clinical trials continues
Strong year-end cash position of $474.1...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics to Report Full Year and Fourth Quarter 2014 Financial Results on Wednesday, March 18
11 mars 2015 08h00 HE
|
Juno Therapeutics
SEATTLE, March 11, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) will announce financial results for the fourth quarter and year ended December 31, 2014 on Wednesday, March 18, 2015...
![Juno Therapeutics Company Logo](/news-release/logo/326601/0/326601.jpg?lastModified=12%2F09%2F2016%2023%3A59%3A56&size=2)
Juno Therapeutics to Present at March 2015 Investor Conferences
24 févr. 2015 08h00 HE
|
Juno Therapeutics
SEATTLE, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) today announced that it will webcast its presentations at the below listed investor conferences in March.
Hans...